These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27411715)

  • 1. Transcriptomic analysis reveals abnormal muscle repair and remodeling in survivors of critical illness with sustained weakness.
    Walsh CJ; Batt J; Herridge MS; Mathur S; Bader GD; Hu P; Dos Santos CC
    Sci Rep; 2016 Jul; 6():29334. PubMed ID: 27411715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA regulatory networks associated with abnormal muscle repair in survivors of critical illness.
    Walsh CJ; Escudero King C; Gupta M; Plant PJ; Herridge MJ; Mathur S; Hu P; Correa J; Ahmed S; Bigot A; Dos Santos CC; Batt J;
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1262-1276. PubMed ID: 35092190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional ability and quality of life in critical illness survivors with intensive care unit acquired weakness: A secondary analysis of a randomised controlled trial.
    Eggmann S; Luder G; Verra ML; Irincheeva I; Bastiaenen CHG; Jakob SM
    PLoS One; 2020; 15(3):e0229725. PubMed ID: 32131082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: intensive care unit acquired weakness.
    Hermans G; Van den Berghe G
    Crit Care; 2015 Aug; 19(1):274. PubMed ID: 26242743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors.
    Meyer-Frießem CH; Malewicz NM; Rath S; Ebel M; Kaisler M; Tegenthoff M; Schildhauer TA; Pogatzki-Zahn EM; Maier C; Zahn PK
    J Intensive Care Med; 2021 Nov; 36(11):1313-1322. PubMed ID: 32799703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients.
    Yang T; Li Z; Jiang L; Xi X
    Muscle Nerve; 2021 Jul; 64(1):77-82. PubMed ID: 33831220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of quality of life and functional ability in patients with ICU acquired Weakness - A post hoc analysis.
    Sidiras G; Patsaki I; Karatzanos E; Dakoutrou M; Kouvarakos A; Mitsiou G; Routsi C; Stranjalis G; Nanas S; Gerovasili V
    J Crit Care; 2019 Oct; 53():223-230. PubMed ID: 31277049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical illness neuromyopathy and the role of physical therapy and rehabilitation in critically ill patients.
    Fan E
    Respir Care; 2012 Jun; 57(6):933-44; discussion 944-6. PubMed ID: 22663968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICU-Acquired Weakness.
    Jolley SE; Bunnell AE; Hough CL
    Chest; 2016 Nov; 150(5):1129-1140. PubMed ID: 27063347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?
    Lee CM; Fan E
    BMC Med; 2012 Oct; 10():115. PubMed ID: 23033976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition.
    Lad H; Saumur TM; Herridge MS; Dos Santos CC; Mathur S; Batt J; Gilbert PM
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic Strategies for ICU-Acquired Weakness. What Can We Learn from Bodybuilders?
    Tarnawski J; Czub M; Dymecki M; Sunil M; Folwarski M
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective.
    Batt J; Herridge MS; Dos Santos CC
    Thorax; 2019 Nov; 74(11):1091-1098. PubMed ID: 31431489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle wasting and early mobilization in acute respiratory distress syndrome.
    Walsh CJ; Batt J; Herridge MS; Dos Santos CC
    Clin Chest Med; 2014 Dec; 35(4):811-26. PubMed ID: 25453427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs.
    Bloch SA; Lee JY; Syburra T; Rosendahl U; Griffiths MJ; Kemp PR; Polkey MI
    Thorax; 2015 Mar; 70(3):219-28. PubMed ID: 25516419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICU-acquired weakness: mechanisms of disability.
    Dos Santos CC; Batt J
    Curr Opin Crit Care; 2012 Oct; 18(5):509-17. PubMed ID: 22918258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscle in critically ill patients].
    Montejo González JC; Sánchez-Bayton Griffith M; Orejón García L
    Nutr Hosp; 2019 Jul; 36(Spec No2):12-17. PubMed ID: 31189318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Care Unit-Acquired Weakness.
    Kramer CL
    Neurol Clin; 2017 Nov; 35(4):723-736. PubMed ID: 28962810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 Intensive Care Unit-Acquired Weakness Compromises Long-Term Functional Status.
    Schmidt D; Margarites AG; Alvarenga LPKB; Paesi PM; Friedman G; Sbruzzi G
    Phys Ther; 2023 Dec; 103(12):. PubMed ID: 37658771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock.
    Schefold JC; Bierbrauer J; Weber-Carstens S
    J Cachexia Sarcopenia Muscle; 2010 Dec; 1(2):147-157. PubMed ID: 21475702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.